The Chemoimmunotherapy Revolution in Resectable NSCLC-The Times They Are A-Changin'

JAMA Oncol. 2024 May 1;10(5):569-570. doi: 10.1001/jamaoncol.2024.0043.

Authors

Christian Rolfo¹, Alessandro Russo²

Affiliations

¹ Center for Thoracic Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York.
² Department of Onco-Hematology, Papardo Hospital, Messina, Italy.

PMID: 38512287
DOI: 10.1001/jamaoncol.2024.0043

No abstract available

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Carcinoma, Non-Small-Cell Lung* / drug therapy
Carcinoma, Non-Small-Cell Lung* / pathology
Humans
Immunotherapy* / methods
Lung Neoplasms* / drug therapy
Lung Neoplasms* / pathology